Learn More
Apexbio Technology LLC Zotarolimus(ABT-578) 221877-54-9 25mg

Supplier: Apexbio Technology LLC B478625
Zotarolimus ABT-578 is a small-molecule inhibitor targeting the immunophilin FKBP12 It is designed to form a complex with FKBP12 thereby inhibiting mTOR pathway signaling and suppressing the proliferation of T-cells vascular smooth muscle cells (VSMCs) and endothelial cells (ECs) Zotarolimus ABT-578 exerts its biological activity primarily through mTOR pathway inhibition In cell-based studies zotarolimus demonstrates nanomolar-level inhibitory potency against human coronary artery cell proliferation and T-cell activation Based on these pharmacological properties zotarolimus ABT-578 holds research potential in vascular restenosis prevention neointimal hyperplasia reduction and immunological studies involving T-cell function
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.